McCann Health promotes Hilary Gentile to global chief strategy officer

News
Hilary Gentile TruthAboutDoctors-37

McCann Health has promoted Hilary Gentile to the newly created position of global chief strategy officer.

Hilary has been with McCann Health for 20 years and served as the chief strategy officer for North America since 2015. She has extensive experience with new product launches, business planning and helping companies across the spectrum of health, wellness and pharmaceuticals. She will report to Global CEO John Cahill.

Among Gentile’s major accomplishments is the adoption of McCann Worldgroup’s Truth 2 Meaning (T2M) strategic planning process across McCann Health, the creation of the proprietary strategic tool Future-Scape and the launch of McCann’s Truth About Doctors study.

Hilary was inducted into the 2017 MM&M Hall of Femme. As one of healthcare marketing's leading strategists, she has become a trusted advisor to some of the largest pharmaceutical companies in the North American region.


Sales & Marketing
Launch Excellence: Moments of Truth
Sponsored

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Patients
Patient Recruitment for Rare Disease Trials Summit banner image
Partner Content

Patient Recruitment for Rare Disease Trials Summit

Recruiting patients for rare disease trials is akin to finding a needle in a haystack, with challenges such as geographical dispersion, low awareness, and limited eligible patient pools.